Form 4: Aspen Aerogels Director Receives Equity Compensation

Director Steven R. Mitchell was granted restricted stock units and stock options as part of the company's annual non-employee director compensation policy.

Summary

• Director Steven R. Mitchell received an equity grant on May 13, 2026.
• The grant consisted of 10,370 Restricted Stock Units (RSUs).
• The grant also included 8,706 stock options with an exercise price of $5.40.
• Both the RSUs and options are scheduled to vest on the earlier of May 13, 2027, or the day prior to the 2027 annual meeting of stockholders.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation with no impact on company operations or financial strategy.

Positives

• Equity-based compensation aligns director interests with long-term shareholder value.
• The grant follows a standard, pre-defined non-employee director compensation policy.

Negatives

• None identified.

Risks

• Standard market risks associated with equity-based compensation and stock price volatility.

Future Outlook

The equity grants vest in one year, contingent upon continued service as a director.

Industry Context

StockSavvy.ai notes that this is a routine disclosure of director compensation, which is standard practice for publicly traded companies to ensure transparency in governance and executive/director remuneration.

Comparison to Industry Standards

• The use of RSUs and stock options for director compensation is consistent with standard corporate governance practices for U.S. mid-cap companies.
• The vesting schedule of one year is typical for annual director equity awards.

Corporate Governance

Stakeholder Impact

• Minimal impact on stakeholders; reflects standard director compensation practices.

Next Steps

• Vesting of equity awards on May 13, 2027.

Key Dates

Keywords

Aspen Aerogels, ASPN, Director Compensation, Form 4, Equity Grant, Insider Transaction